title: Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.
authors.affiliation: Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Building 10, Hatfield CRC, Room 3-5330, 10 Center Drive MSC 1202, Bethesda, MD 20892-1202, USA.
authors.forename: Bipin N
authors.initials: BN
authors.lastname: Savani
authors.forename: Ramaprasad
authors.initials: R
authors.lastname: Srinivasan
authors.forename: Igor
authors.initials: I
authors.lastname: Espinoza-Delgado
authors.forename: Colleen
authors.initials: C
authors.lastname: Dorrance
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Takehito
authors.initials: T
authors.lastname: Igarashi
authors.forename: Katayoun
authors.initials: K
authors.lastname: Rezvani
authors.forename: Andreas
authors.initials: A
authors.lastname: Lundqvist
authors.forename: A John
authors.initials: AJ
authors.lastname: Barrett
authors.forename: Richard W
authors.initials: RW
authors.lastname: Childs
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001752:Blast Crisis; D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate